Course curriculum

    1. Abnormal uterine bleeding in reproductive-aged women - 2Qs (November 2018)

    2. Adnexal mass in premenopausal women - 2Qs (November 2019)

    3. Amenorrhea - Primary - 2Qs (November 2018)

    4. Amenorrhea - Secondary - 2Qs (September 2018)

    5. Amniotic fluid embolism (May 2019)

    6. Annual well-woman examination (March 2023)

    7. Antidepressants and sexual dysfunction - 2Qs (May 2020)

    8. Bacterial vaginosis (May 2021)

    9. Benefits of breastfeeding - 2Qs (July 2019)

    10. Borderline ovarian tumors - 3Qs (January 2022)

    11. BRCA1/2 gene testing (July 2022)

    12. Breast cancer - chemoprophylaxis - 3Qs (July 2019)

    13. Breast cancer - Genitourinary symptoms - 3Qs (January 2019)

    14. Breast cancer screening - 2Qs (January 2022)

    15. Breast cancer survivors - Chronic side effects - 4Qs (July 2018)

    16. Breast cancer – triple negative - 4Qs (May 2019)

    17. Breast imaging of dense breasts (January 2023)

    18. Cardiomyopathy - peripartum - 2Qs (March 2022)

    19. Cervical cancer screening - 2Qs (UPDATED January 2021)

    20. Cervical cancer screening - 2Qs (September 2018)

    21. Cervical cancer screening after age 65 (UPDATED January 2021)

    22. Cervical cancer screening >65 years (January 2019)

    23. Cervical cancer screening <65 years - 2Qs (January 2019)

    24. Cervical polyps (March 2022)

    25. Cervical polyps (July 2018)

    26. Condyloma acuminata - 2Qs (November 2018)

    27. Contraception and cardiovascular disease - 2Qs (May 2019)

    28. Contraception and neurologic disease - 2Qs (March 2019)

    29. Contraception and stroke risk (May 2023)

    30. Contraception in older women - 3Qs (January 2021)

    31. Contraception in women with diabetes - 2Qs (May 2019)

    32. Depression in perimenopause - 2Qs (March 2019)

    33. Discontinuing contraception (January 2021)

    34. Disseminated gonococcal infection - 2Qs (November 2021)

    35. Dysmenorrhea - 2Qs (January 2023)

    36. Emergency contraception - 4Qs (May 2019)

    37. Endometrial cancer - 5Qs (November 2020)

    38. Endometrial polyps - 2Qs (March 2023)

    39. Endometriosis - 2Qs (November 2019)

    40. Galactorrhea (January 2022)

    41. Galactogogues (November 2022)

    42. Gestational diabetes - screening - 2Qs (November 2021)

    43. Gonorrhea - 3Qs (November 2021)

    44. Hair loss in women - 5Qs (September 2021)

    45. Headache in pregnancy - 3Qs (July 2019)

    46. High-grade cervical squamous intraepithelial lesion (July 2018)

    47. Hirsutism in women (November 2019)

    48. HIV and contraception (July 2022)

    49. Imaging of dense breasts - 2Qs (July 2019)

    50. Human trafficking - 2Qs (July 2021)

    51. Intrauterine contraception - 2Qs (November 2018)

    52. Intrauterine devices - hormonal (July 2018)

    53. Intrauterine device - insertion - 2Qs (July 2018)

    54. Intrauterine devices - problems/complications (July 2018)

    55. Intrauterine device - removal (July 2018)

    56. Mechanical heart valve and pregnancy - 2Qs (May 2019)

    57. Menorrhagia - 3Qs (May 2021)

    58. Menstrual migraine - 2Qs (May 2019)

    59. Obesity effect on fertility and pregnancy - 2Qs (November 2022)

    60. Oral contraceptives and risk of venous thromboembolism (March 2020)

    61. Paget's disease of the breast - 2Qs (September 2021)

    62. Pelvic inflammatory disease - 3Qs (March 2022)

    63. Pelvic inflammatory disease - 3Qs (November 2021)

    64. Peri and postmenopausal bleeding - 3Qs (November 2018)

    65. Postpartum eclampsia (January 2019)

    66. Postpartum thyroiditis (July 2020)

    67. Pregnancy and obesity (May 2019)

    68. Premature ovarian insufficiency - 3Qs (May 2022)

    69. Premenstrual syndrome and premenstrual dysphoric disorder - 3Qs (May 2022)

    70. Premature ovarian insufficiency - 3Qs (July 2020)

    71. Progestin-only oral contraceptives (March 2020)

    72. Secondary dysmenorrhea (January 2023)

    73. Sleep problems in women (March 2023)

    74. Syphilis in pregnancy - 2Qs (January 2022)

    75. Tamoxifen - 2Qs (November 2022)

    76. Threatened miscarriage (September 2018)

    77. Transgender breast cancer risk and screening (September 2020)

    78. Trichomoniasis - 2Qs (March 2022)

    79. Trichomoniasis (March 2020)

    80. Triple negative breast cancer (September 2021)

    81. Urinary incontinence - 2Qs (November 2018)

    82. Uterine bleeding - Abnormal (September 2018)

    83. Uterine fibroids - 2Qs (January 2019)

    84. UTI in nonpregnant women - 2Qs (March 2020)

About this course

  • Free
  • 84 lessons
  • 0 hours of video content